NDC 0061-1141 - Orbax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-1141
- Package NDCs from labels
- 0061-1141-01
- Manufacturer
- Merck Sharp & Dohme Corp. | Bimeda, Inc. | Sumitomo Pharma Co., Ltd. | KATAYAMA SEIYAKUSYO CO.,LTD.
- Effective date
- 2023-12-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ORBAX ® Tablets (orbifloxacin) For Oral Use in Dogs and Cats Only | Merck Sharp & Dohme Corp. | Bimeda, Inc. | Sumitomo Pharma Co., Ltd. | KATAYAMA SEIYAKUSYO CO.,LTD. | 2023-12-15 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Orbifloxacin | ACTIVE INGREDIENT | 660932TPY6 | ORBAX (ORBIFLOXACIN) TABLET, COATED [MERCK SHARP & DOHME CORP.] | 1 | |
| Orbifloxacin | ACTIVE MOIETY | 660932TPY6 | ORBAX (ORBIFLOXACIN) TABLET, COATED [MERCK SHARP & DOHME CORP.] | 1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.